Valle d’Aosta
Copyright policy )Valle d’Aosta
In Aosta Valley region 77,9% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 2 cases of cervicocarcinoma and 1 related death and thus results to be cost-effective (33.211 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 1 cancer case could be prevented, with a very similar cost-effectiveness ratio. In Aosta Valley region, the net cost for woman vaccinated is 209 € for the single cohort and 211 € for the multiple cohort.
hpv, Medicine (General), vaccination strategy, R5-920, economic & clinical impact, screening, hpv vaccination, valle d'aosta, cost-effectiveness analysis, aosta valley
hpv, Medicine (General), vaccination strategy, R5-920, economic & clinical impact, screening, hpv vaccination, valle d'aosta, cost-effectiveness analysis, aosta valley
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!